The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
Open accessAbstract
Background & aims Several case series have reported the effects of fecal microbiota transplantation (FMT) for ulcerative colitis (UC). We assessed the efficacy and safety of FMT for patients with UC in a double-blind randomized trial.Methods Patients with mild to moderately active UC (n = 50) were assigned to groups that underwent FMT with feces from healthy donors or were given autologous fecal microbiota (control); each transplant was administered via nasoduodenal tube at the start of the study and 3 weeks later. The study was performed at the Academic Medical Center in Amsterdam from June 2011 through May 2014. The composite primary end point was clinical remission (simple clinical colitis activity index scores ≤2) combined with ≥1-point decrease in the Mayo endoscopic score at week 12. Secondary end points were safety and microbiota composition by phylogenetic microarray in fecal samples.Results Thirty-seven patients completed the primary end point assessment. In the intention-to-treat analysis, 7 of 23 patients who received fecal transplants from healthy donors (30.4%) and 5 of 25 controls (20.0%) achieved the primary end point (P = .51). In the per-protocol analysis, 7 of 17 patients who received fecal transplants from healthy donors (41.2%) and 5 of 20 controls (25.0%) achieved the primary end point (P = .29). Serious adverse events occurred in 4 patients (2 in the FMT group), but these were not considered to be related to the FMT. At 12 weeks, the microbiota of responders in the FMT group was similar to that of their healthy donors; remission was associated with proportions of Clostridium clusters IV and XIVa.Conclusions In this phase 2 trial, there was no statistically significant difference in clinical and endoscopic remission between patients with UC who received fecal transplants from healthy donors and those who received their own fecal microbiota, which may be due to limited numbers. However, the microbiota of responders had distinct features from that of nonresponders, warranting further study. ClinicalTrials.gov Number: NCT01650038.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, in two randomized controlled trials of UC patients, FMT responders showed a higher similarity to their donors than nonresponders. 61,62”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [61]
In the citing paper
“One trial, in which two faecal transplants were given via the upper GI route, showed no difference in clinical or endoscopic remission between the faecal transplant group and the control group (given autologous stool).76”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [76]
In the citing paper
“Since that meta-analysis, two randomised controlled trials in UC show discrepant results.”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [76]
In the citing paper
“Remission (full Mayo score <3 and complete mucosal healing) was achieved in 24% of patients after FMT and 5% with placebo; stool from patients receiving FMT had greater microbial diversity than that of patients given placebo.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [77]
In the citing paper
“In the study by Moayyedi et. al, seventy-five patients with active UC were randomized to a weekly FMT or water enema for 6 weeks, and there was a statistically significant difference in remission, the primary outcome, between the two groups.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [77]
In the citing paper
“However, some researchers did not find significant differences in the efficacy of FMT, which may be related to the number and cycle of enemas, preparation process, and limited numbers (147, 148).”
From Stress triggers flare of inflammatory bowel disease in children and adults (2019) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P. J., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A. D., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,910
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Self-citationCoated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,037
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Self-citationVedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P. J., Sands, B. E., Hanauer, S. B., Colombel, J., Sandborn, W. J., Assche, G. V., Axler, J. L., Kim, H. J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,892
Classification of Inflammatory Bowel Disease
Lennard‐Jones, J. E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091339 · Cited by 2,022
Canoco Reference Manual and User’s Guide: Software for Ordination (version 5.0)
ter Braak, C. J. F., & Šmilauer, P. (2012) · Cited by 1,898
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Claesson, M. J., O’Sullivan, Ó., Wang, Q., Nikkilä, J., Marchesi, J. R., Smidt, H., de Vos, W. M., Ross, R. P., & O’Toole, P. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006669 · Cited by 900
Cited by
Sorted by citations
Items 701–800 of 922
Deterding, K., Spinner, C. D., Schott, E., Welzel, T. M., Gerken, G., Klinker, H., Spengler, U., Wiegand, J., Wiesch, J. S. Z., Pathil, A., et al. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616678364 · Cited by 5
Fecal Microbiota Transplantation
Borody, T. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54843-4.00018-0 · Cited by 7
“We Are What We Eat”: How Diet Impacts the Gut Microbiota in Adulthood
Wang, T., Roest, D. I. M., Smidt, H., & Zoetendal, E. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-28737-5_11 · Cited by 5
Self-citationFecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation
Tikunov, A. Y., Morozov, V. V., Shvalov, А. N., Bardasheva, A. V., Shrainer, E., Maksimova, O. A., Волошина, И. О., Витальевна, М. В., Vlassov, V. V., & Викторовна, Т. Н. (2020) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj20.610 · Cited by 5
Fecal microbial transplant for inflammatory bowel disease
Claytor, J. D., & El‐Nachef, N. (2020) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000676 · Cited by 5
New treatments for ulcerative colitis: do we have pediatric data?
Russell, R. K., Hansen, R., & Turner, D. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1177459 · Cited by 5
Das Darmmikrobiom in der Pathogenese und Therapie chronisch-entzündlicher Darmerkrankungen
Kempski, J., & Huber, S. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01396-8 · Cited by 4
The Role of Intestinal Fungi in the Pathogenesis and Treatment of Ulcerative Colitis
Zhang, Y., Wang, L., & Peng, L. (2025) · Microorganisms · doi:10.3390/microorganisms13040794 · Cited by 4
Doukas, P. G., Doukas, S. G., & Broder, A. (2025) · Digestive Diseases · doi:10.1159/000548568 · Cited by 4
Cutting edge developments and novel targets in IBD: Microbiome in IBD
Deleu, S., & Sabino, J. P. G. (2025) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2025.102060 · Cited by 4
Emerging Therapeutic Approaches for Modulating the Intestinal Microbiota
Cosimato, I., Brescia, A., Franci, G., Casolaro, V., & Folliero, V. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020197 · Cited by 4
Advances and challenges in microbiome transplantation
Sen, P., Kaulmann, D., Youngster, I., Abdeen, S. K., & Elinav, E. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.06.006 · Cited by 4
Řehořová, V., Cibulková, I., Soukupova, H., & Duška, F. (2022) · Future Pharmacology · doi:10.3390/futurepharmacol2010005 · Cited by 4
Banzragch, M., Sanli, K., Stensvold, C. R., Kurt, O., & Arı, Ş. (2023) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2023.2223708 · Cited by 3
Fecal Microbiota Transplantation as Emerging Treatment in European Countries 2.0
Porcari, S., Maida, M. F., Bibbò, S., Mcilroy, J. R., Ianiro, G., & Cammarota, G. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-42108-2_5 · Cited by 4
The role of the fecal microbiota in inflammatory bowel disease
Khalaf, R., Sciberras, M., & Ellul, P. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002818 · Cited by 5
The landscape of new therapeutic opportunities for IBD
Hurtado‐Lorenzo, A., & Swantek, J. L. (2024) · Advances in pharmacology · doi:10.1016/bs.apha.2024.10.011 · Cited by 4
Assessing live microbial therapeutic transmission
Faith, J. J. (2025) · Gut Microbes · doi:10.1080/19490976.2024.2447836 · Cited by 4
Fehily, S. R., Wright, E. K., Basnayake, C., Wilson-O'Brien, A. L., Stanley, A., Marks, E. P., Russell, E., Hamilton, A. L., Bryant, R. V., Costello, S. P., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094714 · Cited by 4
Concepts in Inflammatory Bowel Disease Management
Messaris, E., & Dassopoulos, T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-40232-3.00161-8 · Cited by 4
Fecal Microbiome Transplantation: An Offhand Recipe for Microbiome Therapeutics
Radhakrishanan, A., Kakkar, P., Tandon, C., & Srivastav, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00001-2 · Cited by 4
Ma, J., Chen, T., Ma, X., Zhang, B., Zhang, J., Xu, L., Wang, Y., Huang, J., Liu, Z., Wang, F., et al. (2022) · BioMedical Engineering OnLine · doi:10.1186/s12938-022-01046-y · Cited by 4
Evaluation of microbial and vancomycin treatments in ulcerative colitis in murine models
Hasan, N., & Yang, H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285613 · Cited by 4
Fecal Transplant: The Benefits and Harms of Fecal Microbiota Transplantation
Goldenberg, D., & Melmed, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-46712-7_9 · Cited by 4
Das Mikrobiom des Darms beim kritisch kranken Patienten
Salzberger, B., & Rauscher, C. (2015) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-015-0078-z · Cited by 4
Shah, S. C., Faith, J. J., & Colombel, J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.081 · Cited by 4
Gut microbes as a therapeutic armory
Bhardwaj, N., & Geva‐Zatorsky, N. (2018) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2019.08.007 · Cited by 4
Hmar, E. B. L., Paul, S., Boruah, N., Sarkar, P., Borah, S., & Sharma, H. K. (2021) · Current Pathobiology Reports · doi:10.1007/s40139-020-00218-6 · Cited by 4
Gîlcă-Blanariu, G.-E., Ștefănescu, G., Gîrleanu, I., Iqbal, T. H., Segal, J. P., Mullish, B. H., Quraishi, M. N., Keller, J. J., Molnár, T., Mégraud, F., et al. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3297 · Cited by 4
An integrated understanding of the immunology of allograft inflammation
Houlihan, B. K., Cha, P., ZASLOFF, M. A., Fishbein, T., & Kroemer, A. (2017) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000395 · Cited by 4
Gut health and the personal microbiome
Kolmeder, C. A., & de Vos, W. M. (2017) · Wiley eBooks · doi:10.1002/9781119101277.ch10 · Cited by 4
Characteristics of gut microbiota and metabolites in patients with ulcerative colitis with fatigue
Liu, Z.-X., Liu, X.-Y., Tan, W.-W., Zhang, W.-B., Zhang, Y.-L., Zheng, L., & Dai, Y.-C. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i3.115264 · Cited by 3
Rynikova, M., Bojcukova, V., & Demečková, V. (2026) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848261437918 · Cited by 3
Alternative & complementary treatment for pediatric inflammatory bowel disease
Rimon, R. M., & Shaoul, R. R. (2019) · Translational Pediatrics · doi:10.21037/tp.2019.09.02 · Cited by 3
Update on Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease.
Allegretti, J. R. (2021) · PubMed Central · Cited by 3
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice
Rossier, L., Matter, C., Burri, E., Galpérine, T., Hruz, P. L., Juillerat, P., Schoepfer, A. M., Vavricka, S. R., Zahnd, N., Décosterd, N., et al. (2023) · Swiss Medical Weekly · doi:10.57187/smw.2023.40100 · Cited by 4
Vestal, R. (2015) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2015.08.006 · Cited by 3
Miyoshi, J., Qiao, Y., & Chang, E. B. (2017) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2017.09.005 · Cited by 3
Gut Homeostasis; Microbial Cross Talks in Health and Disease Management
Khatri, G. S., Kurian, C., Anand, A., & Paari, K. A. (2021) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.9.3.28 · Cited by 3
Current Applications and Future Prospects of Fecal Microbiota Transplantation
Ishikawa, D., Zhang, X., & Nagahara, A. (2025) · Juntendō Igaku/Juntendo igaku · doi:10.14789/ejmj.jmj24-0045-r · Cited by 3
Fecal Microbiota Transplantation as Therapy for Inflammatory Bowel Disease
Schneider, A., & Maric, L. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811388-2.00028-2 · Cited by 3
Power calculations for detecting differences in efficacy of fecal microbiota donors
Olesen, S. W. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100674 · Cited by 3
Faecal microbiota transplantation: what’s beyond Clostridium difficile infection?
Tamilarasan, A. G., & Krishnananthan, T. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001938 · Cited by 3
The Gut Microbiota and Inflammatory Bowel Disease
Conrad, M. A., Wu, G. D., & Kelsen, J. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-14744-9_4 · Cited by 3
FMT in Clostridium difficile and Other Potential Uses
Fine, S., & Kelly, C. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00034-3 · Cited by 3
The Human Microbiome: An Emerging Key Player in Health and Disease
Blum, H. E. (2017) · Archives of Clinical and Biomedical Research · doi:10.26502/acbr.5017009 · Cited by 3
Microbiome and Diseases: Inflammatory Bowel Diseases
Hildner, K., Waldschmitt, N., & Haller, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_11 · Cited by 3
Gut dysbiosis and its epigenomic impact on disease
Odenwald, M. A., & Chapman, C. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816843-1.00025-4 · Cited by 3
Palmer, B. S., Metcalfe, C. D., Fraser, A., & Creed, T. (2016) · Cogent Medicine · doi:10.1080/2331205x.2016.1233685 · Cited by 3
Lo, K., Kavarian, P., Wang, B., Parsana, R., Durazo-arvizu, R., Sun, F., & Michail, S. (2024) · Gut microbes reports · doi:10.1080/29933935.2024.2393219 · Cited by 4
Optimizing Therapeutic Potential of Fecal Transplant in Inflammatory Bowel Disease
Magier, S., Morley, T. S., & Kelly, C. R. (2025) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2024.12.002 · Cited by 2
Zhang, X., Ishikawa, D., & Nagahara, A. (2025) · International Immunology · doi:10.1093/intimm/dxaf038 · Cited by 3
Zhu, Y., Ding, X., Wang, X., Zhou, C., Sheng, Y., Li, M., Yu, Y., Zhu, F., & Zhang, Y. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158582 · Cited by 2
Massaro, M., Vansia, J., & McGill, S. (2020) · ACG Case Reports Journal · doi:10.14309/crj.0000000000000364 · Cited by 2
Pacuta, I., Gancarčíková, S., Lauko, S., Hajdučková, V., Janíčko, M., Demečková, V., Rynikova, M., Adamkova, P., Mudroňová, D., Ambro, Ľ., et al. (2024) · Applied Sciences · doi:10.3390/app14114856 · Cited by 2
Intestinal Microbiology and Ecology in Crohn’s Disease and Ulcerative Colitis
Buttó, L. F., & Haller, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-33703-6_4 · Cited by 2
Medikamentöse Therapie der Colitis ulcerosa und Pouchitis
Biedermann, L., & Rogler, G. (2020) · Springer eBooks · doi:10.1007/978-3-662-59104-8_20 · Cited by 2
Microbiome and Chronic Pelvic Pain
Bazzocchi, G., Balloni, M., & Turroni, S. (2020) · Urodynamics, neurourology and pelvic floor dysfunctions · doi:10.1007/978-3-030-56387-5_11 · Cited by 2
Fecal microbiota transplantation – where are we?
Mikolašević, I., Hauser, G., Abram, M., Filipec, T., Kanižaj, Radić, M., Zrnić, I. K., & Zrnić (2021) · Croatian Medical Journal · doi:10.3325/cmj.2021.62.52 · Cited by 2
Jo, H. G., & Seo, G. S. (2021) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2021.089 · Cited by 2
Faecal microbiota transplantation associated adverse events
Patryn, R. K., Kaźmierczak-Wojtaś, N., Bułaś, L., Boretska, O., Szkultecka-Dębek, M., Drozd, M., & Blicharski, T. (2024) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2024-0028 · Cited by 2
[Fecal microbiota transplantation therapy for patients with gastrointestinal tract diseases].
Osada, T., Ishikawa, D., & Watanabe, S. (2015) · PubMed · doi:10.11405/nisshoshi.112.1973 · Cited by 2
Fecal Microbiota Transplants: Current Knowledge and Future Directions
Chis, R., Sheth, P. M., & Petrof, E. O. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7534-1_11 · Cited by 2
Current Status of Fecal Microbiota Transplantation
Reygner, J., & Kapel, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00016-6 · Cited by 2
Schulte, L.-A., Schäfer, A., Steding, K., Rauschek, L., & Klaus, J. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1010-6920 · Cited by 2
Is a Fecal Microbiota Transplant Useful for Treating Inflammatory Bowel Disease?
Suceveanu, A., Andrada, D., Musat, M., Voinea, F., Voinea, F., Parepa, I. R., Stoian, A. P., Mazilu, L., & Suceveanu, A. P. (2020) · Biochemistry · doi:10.5772/intechopen.91444 · Cited by 2
Fermented Foods in Medicine: An Evaluation of Their Uses and Effects on the Human Gut Microbiota
Elkridge, M., & Storm, E. (2020) · Life The Excitement of Biology · doi:10.9784/leb8(2)storm.01 · Cited by 2
Evaluation of the Levels of Metabolites in Feces of Patients with Inflammatory Bowel Diseases
Zhgun, E. S., Kislun, Y. V., Калачнюк, Т. Н., Veselovsky, V. A., Urban, A., Tikhonova, P., Pavlenko, A. V., Ilchenko, G. N., & Ilina, E. N. (2020) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750820040113 · Cited by 2
Schmidt, F., & Siegmund, B. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_20 · Cited by 2
Ткач, С. М., Dorofeyev, A., Kuzenko, I., Boyko, N., Falalyeyeva, T. M., & Kobyliak, N. M. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-19564-8_10 · Cited by 2
Interactions Between Microbial Therapeutics and the Endogenous Microbiome
Hallowell, H. A., Gao, A. L., Kelly, K. E., & Suez, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-1463-0_21 · Cited by 2
Fecal Microbiota Transfer and Inflammatory Bowel Disease
Newman, K. M., Moscoso, C. G., & Vaughn, B. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00045-2 · Cited by 2
Peyrottes, A., Seksik, P., Dore, J. M., & Marteau, P. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-11446-6_24 · Cited by 2
Maladies inflammatoires chroniques de l’intestin de l’adulte et microbiote
Rivière, P. (2020) · Côlon & Rectum · doi:10.3166/cer-2020-0142 · Cited by 2
Jaillier-Ramírez, A. M., Waitzberg, D. L., & Becerra, J. A. (2021) · Revista de Nutrición Clínica y Metabolismo · doi:10.35454/rncm.v4n4.287 · Cited by 3
Bakker, G. J., & Nieuwdorp, M. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch12 · Cited by 2
Improving causality in microbiome research: can human genetic epidemiology help?
Wade, K. H., & Hall, L. J. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15628.2 · Cited by 2
Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet?
Lim, M. H., & Radford‐Smith, G. L. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14228 · Cited by 2
Development of early-stage type 1 diabetes in germ-free interleukin-10 deficient micePreprint
Bobe, A. M., Miyoshi, J., Moore, P. C., Devkota, S., Leone, V., Martinez, K., Theriault, B. R., Musch, M. W., Wasserfall, C. H., Atkinson, M. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.18.048272 · Cited by 2
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?
Claytor, J. D., & Faith, J. J. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.07.047 · Cited by 2
Donor Screening for Fecal Microbiota Transplantation
Lee, H. H., & Cho, Y. (2020) · Korean Journal of Medicine · doi:10.3904/kjm.2020.95.3.181 · Cited by 1
Alteration of Gut microbiota during HIV infection
Altın, K. H. (2023) · Bioengineering Studies · doi:10.37868/bes.v4i1.id247 · Cited by 1
Searching for the perfect match: MINDFUL trial pairs FMT and fiber for ulcerative colitis
Bartu, L., & Faith, J. J. (2025) · Med · doi:10.1016/j.medj.2025.100842 · Cited by 1
Sabir, A., Jabeen, S., Kamran, H., Farooq, S., & Bashir, F. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70335 · Cited by 1
Biscaglia, G., Gentile, A., Parente, P., Calvo, A., Fontana, R., Continisio, A., Brina, A. L. P. D., Ciardiello, D., McIlwain, G., Latiano, A., et al. (2025) · Nutrients · doi:10.3390/nu17233788 · Cited by 1
Microbial shifts in early life: the pediatric gut microbiome and its role in health and disease
Waghmode, S., Viswanathan, R., Koligudde, V., Umare, P., & Lavania, M. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2681763 · Cited by 1
Update on Fecal Microbiota Transplantation In Inflammatory Bowel Diseases
Kwok, S., Choi, B., Choi, J. H., Bassi, S., & Shih, D. Q. (2018) · doi:10.32392/biomed.27 · Cited by 1
Pathogenese chronisch-entzündlicher Darmerkrankungen
Siegmund, B. (2020) · Springer eBooks · doi:10.1007/978-3-662-59104-8_3 · Cited by 1
Nutritional and Botanical Approaches for Inflammatory Bowel Disease
Lucius, K. (2021) · Alternative and Complementary Therapies · doi:10.1089/act.2021.29331.klu · Cited by 1
Clinical Utility and Alterations in Bacterial Flora in Fecal Microbiome Transplantation
Dave, A. A., & Robson, R. L. (2015) · International Journal of Medical Students · doi:10.5195/ijms.2015.135 · Cited by 1
Fäkale Mikrobiotatransplantation (FMT)
Lübbert, C. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0125-2 · Cited by 1
Das Mikrobiom als Therapieziel bei funktionellen und chronisch entzündlichen Magen-Darm-Erkrankungen
Langhorst, J., & Koch, A. K. (2017) · Erfahrungsheilkunde · doi:10.1055/s-0043-109501 · Cited by 1
Human Microbiota and Autoimmune Diseases
Resende, G. G., & de Carvalho, J. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814307-0.00020-7 · Cited by 1
Seidelin, J. B., & Burisch, J. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-11446-6_23 · Cited by 1
Chronisch-entzündliche Darmerkrankungen
Zeißig, S. (2019) · Die Gastroenterologie · doi:10.1007/s11377-019-00388-9 · Cited by 1
Gut Microbiome and Gastrointestinal Disorders
Legaki, E., Karanasou, E. A., & Gazouli, M. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_3 · Cited by 2
Faecal transplantation and Clostridioides difficile infection
Knežević, D., & Petković, M. R. (2021) · Scripta Medica · doi:10.5937/scriptamed52-32752 · Cited by 1
Gut Microbiota Characteristics in Ulcerative Colitis and other Gastrointestinal Diseases
El-Lehleh, A., Elabd, N. S., Azmy, R. M., Tselepis, C., & Shaheen, W. (2021) · Afro-Egyptian Journal of Infectious and Endemic Diseases · doi:10.21608/aeji.2021.90989.1167 · Cited by 1
Paulina Núñez, F., Quera, R., Constanza Bay, M., & Pamela Thomson, M. (2022) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2021.05.005 · Cited by 1
Das, K., Upadhyay, S., & Oli, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00021-8 · Cited by 2
Metadata
- Authors
- Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., Zoetendal, E. G., D’Haens, G. R., & Ponsioen, C. Y.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Wageningen University & Research (NL)
- Corresponding author
- Ponsioen, Cyriel Y.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 149
- Issue
- 1
- Pages
- 110-118.e4
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1994882377
- Cited by
- 921
- References
- 29
- Citations by year
- 2026: 30 · 2025: 45 · 2024: 64 · 2023: 69 · 2022: 86 · 2021: 93 · 2020: 128 · 2019: 113 · 2018: 84 · 2017: 87 · 2016: 83 · 2015: 36
- FWCI
- 66.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- fecal microbiota transplantation, ulcerative colitis, clinical remission, endoscopic remission, Clostridium cluster XIVa, Clostridium cluster IV, gut microbiota composition, adverse events
- MeSH terms
- Adult, Aged, Biological Therapy, Colitis, Ulcerative, Double-Blind Method, Feces, Female, Humans, Intubation, Gastrointestinal, Male, Middle Aged, Remission Induction, Treatment Outcome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
